You ask the questions - we develop the answers.

We combine professional management with scientific expertise.

The Institute for Pharmacology and Preventive Medicine

The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.

Icon Klinische Register

Registries / Studies

Registries and studies across Europe are our expertise.

read more

Icon Prüfzentrum

Validation Centre

We validate the accuracy of your blood pressure monitors.

read more

Icon Beratung

Consulting

Trustworthy advice of a medical doctor and a pharmacist.

read more

IPPMed Partnership

Prof. Dr. Peter Bramlage (physician) and Dr. Johannes Hankowitz (pharmacist) work closely together in the Institute for Pharmacology and Preventive Medicine, Dr. Bramlage & Dr. Hankowitz Partnership. Dr Bramlage focuses on collaboration with partners from industry and universities on scientific questions and the evaluation and publication of study data. Dr Hankowitz is experienced in the preparation and assessment of drug evaluations within the AMNOG (Pharmaceuticals Market Reorganisation Act) and editor of AMNOG-monitor.

IPPMed GmbH

Our activities in the areas of clinical registries and validation of blood pressure monitoring devices are a part of IPPMed – Institute for Pharmacology and Preventive Medicine GmbH. This is managed by Prof. Dr. Peter Bramlage and led by Dr. Claudia Lüske and Dr. Beate Botta. Here, together with the highly experienced staff at our office in Cloppenburg, we regularly carry out large scale projects involving the latest pharmaceuticals and medical devices.
The close collaboration with clients, as well as with external investigators, ensures the high quality of our work. We focus primarily on cardiovascular indications, hypertension, thrombosis, and diabetes.

Scientific Fellow wanted!


We are looking for a Scientific Fellow in the field of registries / studies for our office located in Cloppenburg.

Recent Activity / Publications in press


Kolwelter J, Bosch A, Jung S, Stapel L, Kennenkeril D, Ott C, Bramlage P, Schiffer M, Achenbach S, Schmieder RE. Effects of the SGLT2 inhibitor empagliflozin on vascular function in patients with chronic heart failure. ESC Heart Failure 2021.

McCalmont G, Durand E, Lauck S, Muir DF, Spence MS, Vasa-Nicotera M, Wood D, Saia F, Chatel N, Lüske CM, Kurucova J, Bramlage P, Frank D. Setting a Benchmark for Resource Utilization and Quality of Care in Patients undergoing Transcatheter Aortic Valve Implantation in Europe – rationale and design of the international BENCHMARK registry. Clin Cardiol 2021.

Studencan M, Pella D, Bramlage P, Kaszasova E. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Archives of Medical Science 2021.

PubMed listed Publications


Our Partners


logo S4TRAILS
Logo da-cro
Logo Antepuls

Logo IHF
logo S4TRAILS